A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants
Clinical trial NCT04023994 · COMPLETED
Trial details
- NCT number
- NCT04023994
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-03
- Primary completion
- 2020-07-17
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.